Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Orally active GnRH antagonist evaluated in preclinical models by Abbott investigators

June 18, 1999

A-198401: another compound emerges from Abbott's focus on nonpeptide GnRH antagonists

June 18, 1999

Ono claims new series of matrix metalloproteinase inhibitors

June 18, 1999

Schering-Plough launches alkylating agent in second major market

June 18, 1999

GnRH antagonist A-222509: coadministration with ritonavir improves potency and PK

June 18, 1999

Cytogen acquires Prostagen, forms joint venture with Progenics

June 18, 1999

Selective, efficacious chemosensitizer discovered

June 18, 1999

Phenolic hormone inhibits smooth muscle cells in prostate tissue

June 18, 1999

Uncarinic acids with anticancer potential

June 18, 1999

New tyrosine kinase inhibitor series presented by Pfizer

June 17, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...